Biogen Inc. will invest approximately $200 million to build a new gene therapy manufacturing facility at its Research Triangle Park (RTP) campuses in North Carolina. The company will expand its existing operations and add approximately 90 new jobs to its workforce of approximately 1,900 employees at both RTP campuses.
“We plan to build differentiated, sustainable and advanced manufacturing capabilities to support our gene therapy programs and collaborations,” said Nicole Murphy, Senior Vice President, Global Manufacturing and Technical Operations, Biogen.
